Ingevity Future Growth
Future criteria checks 3/6
Ingevity is forecast to grow earnings and revenue by 116.9% and 3.2% per annum respectively while EPS is expected to grow by 116.8% per annum.
Key information
116.9%
Earnings growth rate
116.8%
EPS growth rate
Chemicals earnings growth | 16.8% |
Revenue growth rate | 3.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 Dec 2024 |
Recent future growth updates
Recent updates
What Ingevity Corporation's (NYSE:NGVT) 32% Share Price Gain Is Not Telling You
Nov 07Is Ingevity (NYSE:NGVT) A Risky Investment?
Oct 13Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares
Sep 08Ingevity: The Risk-Reward Ratio Is Still Unfavorable
Aug 27Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 03Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky
Jul 13Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?
Jun 14Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?
Apr 18Is Ingevity (NYSE:NGVT) A Risky Investment?
Mar 22What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?
Jan 23Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares
Jan 04These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts
Nov 10Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Oct 07Ingevity Corporation: The Risk To Reward Is Currently Favorable
Oct 06Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Sep 22Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?
Aug 11Ingevity Corporation: Headwinds Are Temporary
Jul 05Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt
Jun 21Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?
May 29We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
Feb 16Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?
Jan 25Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate
Sep 13Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?
Aug 22Ingevity to acquire pavement marking materials business Ozark Materials for $325M
Aug 02Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly
Aug 01Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends
Jun 05What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?
May 20Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist
May 03We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt
May 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,575 | 172 | 163 | 278 | 2 |
12/31/2025 | 1,462 | 144 | 137 | 247 | 3 |
12/31/2024 | 1,416 | -442 | 1 | 112 | 3 |
9/30/2024 | 1,479 | -564 | 28 | 110 | N/A |
6/30/2024 | 1,548 | -431 | 72 | 169 | N/A |
3/31/2024 | 1,640 | -112 | 87 | 188 | N/A |
12/31/2023 | 1,692 | -5 | 95 | 205 | N/A |
9/30/2023 | 1,704 | 127 | 128 | 257 | N/A |
6/30/2023 | 1,740 | 177 | 120 | 252 | N/A |
3/31/2023 | 1,678 | 202 | 154 | 294 | N/A |
12/31/2022 | 1,668 | 212 | 171 | 313 | N/A |
9/30/2022 | 1,621 | 225 | 160 | 291 | N/A |
6/30/2022 | 1,516 | 146 | 171 | 291 | N/A |
3/31/2022 | 1,454 | 130 | 152 | 266 | N/A |
12/31/2021 | 1,392 | 118 | 190 | 293 | N/A |
9/30/2021 | 1,381 | 135 | 273 | 370 | N/A |
6/30/2021 | 1,336 | 209 | 272 | 360 | N/A |
3/31/2021 | 1,248 | 185 | 264 | 343 | N/A |
12/31/2020 | 1,216 | 181 | 270 | 352 | N/A |
9/30/2020 | 1,194 | 180 | 199 | 285 | N/A |
6/30/2020 | 1,222 | 170 | 222 | 313 | N/A |
3/31/2020 | 1,304 | 206 | 238 | 344 | N/A |
12/31/2019 | 1,293 | 184 | 161 | 276 | N/A |
9/30/2019 | 1,268 | 182 | 159 | 276 | N/A |
6/30/2019 | 1,219 | 171 | 131 | 252 | N/A |
3/31/2019 | 1,175 | 161 | 126 | 234 | N/A |
12/31/2018 | 1,134 | 169 | 158 | 252 | N/A |
9/30/2018 | 1,085 | 169 | 134 | 207 | N/A |
6/30/2018 | 1,037 | 153 | N/A | 193 | N/A |
3/31/2018 | 989 | 138 | N/A | 178 | N/A |
12/31/2017 | 972 | 127 | N/A | 174 | N/A |
9/30/2017 | 954 | 94 | N/A | 187 | N/A |
6/30/2017 | 942 | 53 | N/A | 144 | N/A |
3/31/2017 | 927 | 45 | N/A | 131 | N/A |
12/31/2016 | 908 | 35 | N/A | 128 | N/A |
9/30/2016 | 898 | 34 | N/A | 111 | N/A |
6/30/2016 | 902 | 64 | N/A | 100 | N/A |
3/31/2016 | 919 | 66 | N/A | 92 | N/A |
12/31/2015 | 958 | 80 | N/A | 72 | N/A |
9/30/2015 | 999 | 99 | N/A | 76 | N/A |
6/30/2015 | 1,025 | 115 | N/A | 111 | N/A |
3/31/2015 | 1,022 | 121 | N/A | 106 | N/A |
12/31/2014 | 1,036 | 129 | N/A | 139 | N/A |
12/31/2013 | 980 | 119 | N/A | 137 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NGVT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: NGVT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NGVT is expected to become profitable in the next 3 years.
Revenue vs Market: NGVT's revenue (3.2% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: NGVT's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NGVT's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/29 13:44 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ingevity Corporation is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Paretosh Misra | Berenberg |
John McNulty | BMO Capital Markets Equity Research |
Mark Weintraub | Buckingham Research Group Inc. |